Exec to Get $77M for Whistle-Blowing
CHICAGO (AP) _ A former executive of TAP Pharmaceutical Products Inc. will receive a record $77 million reward from the federal government for blowing the whistle on his employer’s crimes.
Douglas Durand brought to light the health-care fraud committed by TAP, which agreed last week to pay $875 million in civil and criminal penalties and to plead guilty to conspiring to overbill government insurers for the prostate cancer drug Lupron.
Durand brought the fraud to light in 1996 when he filed a lawsuit under the federal False Claims Act, prosecutors said. A second whistle-blower will be paid $17 million from the $558 million in civil penalties levied against TAP.
Durand’s attorney, Elizabeth Ainslie, said her client did not want to speak to reporters.
TAP officials have said the company is taking steps to ensure the illegal practices never happen again.
Lake Forest-based TAP is a joint venture between Abbott Laboratories, of Abbott Park, Ill., and Takeda Chemical Industries Ltd. in Japan.